SCHEMBL18134205

SCHEMBL18134205

CCOc1cc(C)nc(N)n1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NUDT1 P36639 3/20 0.66
▸ POLB P06746 1/20 0.64
▸ NPC1 O15118 3/20 0.56
▸ RAB9A P51151 2/20 0.56
▸ ALDH1A1 P00352 1/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ SMN1; SMN2 Q16637 3/20 0.54
▸ CYP1A2 P05177 2/20 0.51
▸ CYP2C19 P33261 2/20 0.51
▸ CYP2C9 P11712 1/20 0.49
▸ RECQL P46063 1/20 0.49
▸ TSHR P16473 2/20 0.44
▸ LMNA P02545 3/20 0.43
▸ TLR8 Q9NR97 1/20 0.42
▸ HSP90AA1 P07900 1/20 0.41
▸ HSP90AB1 P08238 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ USP2 O75604 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1576650 0.87 NPC1 (0.62) NUDT1POLBNPC1RAB9AALDH1A1
SCHEMBL11099815 0.85 NUDT1 (0.62) NUDT1POLBNPC1RAB9AALDH1A1
SCHEMBL12074772 0.82 NUDT1 (0.64) NUDT1POLBNPC1RAB9AALDH1A1
SCHEMBL4564977 0.82 NUDT1 (0.58) NUDT1POLBNPC1RAB9AALDH1A1
SCHEMBL2800474 0.82 NPC1 (0.57) NUDT1POLBNPC1RAB9AALDH1A1
SCHEMBL20606933 0.82 SMN1; SMN2 (0.45) NUDT1POLBNPC1RAB9AALDH1A1
SCHEMBL8630748 0.80 NPC1 (0.56) NUDT1POLBNPC1RAB9AALDH1A1
SCHEMBL18072499 0.79 NUDT1 (1.00) NUDT1POLBNPC1RAB9AALDH1A1
SCHEMBL10752783 0.79 NUDT1 (0.60) NUDT1POLBNPC1RAB9AALDH1A1
SCHEMBL13012202 0.79 SMN1; SMN2 (0.50) NUDT1POLBNPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682950-B2 Thiophene-2-carboximidamide based selective neuronal nitric oxide synthase inhibitors NORTHWESTERN UNIVERSITY (US) 2017-06-20 — — US disclosed
US-9636288-B2 Means for oxidative dyeing of keratin fibers containing novel tetra-substituted derivatives of pyrimidine HENKEL AG & CO. KGAA (DE) 2017-05-02 — — US disclosed
US-20160296447-A1 MEANS FOR OXIDATIVE DYEING OF KERATIN FIBERS CONTAINING NOVEL TETRA-SUBSTITUTED DERIVATIVES OF PYRIMIDINE HENKEL AG & CO. KGAA (DE) 2016-10-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160296447-A1 MEANS FOR OXIDATIVE DYEING OF KERATIN FIBERS CONTAINING NOVEL TETRA-SUBSTITUTED DERIVATIVES OF PYRIMIDINE KRT18, TK1, DPYD NUDT1 109/4885POLB 224/4885NPC1 4445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback